Osaic Holdings
GPCR icon

Osaic Holdings’s Structure Therapeutics GPCR Stock Holding History

Osaic Holdings’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Buy
44,786
+370
+0.8% +$16.4K ﹤0.01% 2156
2026
Q1 		$2.14M Sell
44,416
-14,822
-25% -$1.01M ﹤0.01% 2015
2025
Q4 		$4.12M Sell
59,238
-3,601
-6% -$147K 0.01% 1503
2025
Q3 		$1.23M Sell
62,839
-523
-0.8% -$10.4K ﹤0.01% 2606
2025
Q2 		$1.31M Buy
63,362
+31,972
+102% +$703K ﹤0.01% 2271
2025
Q1 		$543K Buy
31,390
+598
+2% +$14.6K ﹤0.01% 2787
2024
Q4 		$835K Buy
30,792
+30,272
+5,822% +$1.07M ﹤0.01% 2343
2024
Q3 		$22.8K Buy
520
+22
+4% +$851 ﹤0.01% 5298
2024
Q2 		$19.6K Sell
498
-944
-65% -$38.8K ﹤0.01% 5363
2024
Q1 		$61.8K Buy
1,442
+231
+19% +$9.74K ﹤0.01% 4587
2023
Q4 		$49.3K Buy
1,211
+655
+118% +$37.5K ﹤0.01% 4919
2023
Q3 		$28K Buy
+556
New +$17.9K ﹤0.01% 5370

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Osaic Holdings's GPCR Position: Q2 2026 in Review

Osaic Holdings increased its Structure Therapeutics (GPCR) stake by 0.83% in Q2 2026, buying an estimated $16.4K and bringing the position to 44,786 shares worth $2.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

Osaic Holdings first reported a position in GPCR in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.12M in Q4 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Osaic Holdings held 44,786 shares of Structure Therapeutics worth $2.4M as of Q2 2026.
  • Osaic Holdings bought 370 Structure Therapeutics shares in Q2 2026, an estimated $16.4K.
  • Structure Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #2156 holding.
  • Osaic Holdings first reported a position in Structure Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • Osaic Holdings's Structure Therapeutics position peaked at $4.12M in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.